ArticleJACC. Case reports2026
Ventricular Tachycardia in a Young Athlete With Prior Myocarditis and MYL2 Mutation.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMyocarditis and inherited cardiomyopathies are important causes of malignant arrhythmias in young athletes. CASE SUMMARY: A 23-year-old female competitive soccer player presented with exertional chest discomfort, dizziness, and syncope. Troponin elevation and cardiac magnetic resonance with subepicardial late gadolinium enhancement of the inferolateral wall were thought to be consistent with acute myocarditis. She recovered after activity restriction and had normal follow-up magnetic resonance imaging, echocardiogram, and cardiopulmonary exercise testing. During monitored return to play, she developed a 42-second episode of polymorphic ventricular tachycardia while sprinting, leading to subcutaneous implantable cardioverter-defibrillator placement for secondary prevention. Genetic testing revealed a pathogenic MYL2 variant; her mother, brother, and sister carry the same mutation. DISCUSSION: This case highlights the overlap between myocarditis, genetic susceptibility, and exercise-triggered polymorphic ventricular tachycardia, and the challenges of risk stratification and return-to-play decisions in genotype-positive athletes with prior malignant arrhythmia. TAKE-HOME MESSAGE: Myocarditis may unmask occult genetic substrates, and return-to-play decisions require individualized shared decision-making in the context of incomplete risk data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.